Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Identification of miRNA targets with stable isotope labeling by amino acids in cell culture.
PMID 16945957 · PMC1636363 · Nucleic acids research · 2006 · 8 claims · 4 setups
SILAC can be used for miRNA target identification
-
Full-text index only
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
PMID 17238276 · PMC1626102 · PLoS pathogens · 2006 · 8 claims · 8 setups
SILAC-based quantitative membrane proteomics can identify novel targets of viral immunomodulators in an unbiased manner
-
Full-text index only
The impact of microRNAs on protein output.
PMID 18668037 · PMC2745094 · Nature · 2008 · 8 claims · 8 setups
MicroRNA targeting for protein repression occurs primarily through seed-matched sites (6mer, 7mer-A1, 7mer-m8, 8mer) located in favourable predicted contexts within 3′ UTRs
-
Full-text index only
Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.
PMID 19651622 · PMC2816010 · Molecular & cellular proteomics : MCP · 2009 · 7 claims · 4 setups
Less than 10% of quantified phosphopeptides showed a response pattern indicative of being direct targets of the MAPK inhibitors U0126 or SB202190.
-
Full-text index only
A new era for proteomics research?
PMID 19014405 · PMC2614486 · Genome biology · 2008 · 8 claims · 8 setups
Refined mass spectrometry instrumentation and software now make whole-proteome coverage of model organisms in a single experiment conceivable
-
Full-text index only
The cancer secretome: a reservoir of biomarkers.
PMID 18796163 · PMC2562990 · Journal of translational medicine · 2008 · 8 claims · 8 setups
Cancer secretome analysis is a promising reservoir for identifying novel, non-invasive cancer biomarkers, addressing limitations of whole blood/serum proteomics
-
Full-text index only
Proteomic approaches to cancer biomarkers.
PMID 19931265 · PMC2873613 · Gastroenterology · 2010 · 8 claims · 8 setups
Combining abundant-protein depletion, offline fractionation, and subproteome (e.g., glycoproteome) enrichment with 2D LC-MS/MS increases the dynamic range and depth of blood proteome analysis for biomarker discovery.
-
Full-text index only
Comparing cellular proteomes by mass spectrometry.
PMID 19886975 · PMC2784314 · Genome biology · 2009 · 8 claims · 6 setups
MS-based proteomics combined with cryo-electron tomography (CET) enables determination of absolute and relative protein abundances and localization